[Central giant cell granuloma in the mandible. Therapy in a 13-year-old patient with denosumab].

Swiss Dent J

Klinik für Oral Health & Medicine, Universitäres Zentrum für Zahnmedizin Basel (UZB), Universität Basel, Basel, Schweiz.

Published: July 2022

Central giant cell granuloma (CGG) is a benign intraosseous osteolytic jaw lesion that accounts for approx. 7% of all benign jaw tumours. Inflammatory, infectious or neoplastic processes are cited as the cause of ZRZG, with genetic components also playing a role. Children or young adults before the age of 30 and women are typically affected.

Download full-text PDF

Source
http://dx.doi.org/10.61872/sdj-2022-07-08-04DOI Listing

Publication Analysis

Top Keywords

giant cell
8
cell granuloma
8
[central giant
4
granuloma mandible
4
mandible therapy
4
therapy 13-year-old
4
13-year-old patient
4
patient denosumab]
4
denosumab] central
4
central giant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!